Innovest Global Inc. Signs Letter of Intent to Acquire 20% of StemVax Therapeutics, a Biotechnology & Health Sciences Company
Innovest Global Inc. to Launch Biotech and Health Sciences Division Led by World Renowned Neuroscientist, Dr. Dwain Morris-Irvin